实时超声引导心包、胸、腹腔穿刺行腔内灌注介入化疗

Real-time Ultrasound-guided Interventional Chemotheraphy Via Pericarcial,Pleural and Peritoneal Cavities

报道实时超声引导心包腔或胸、腹腔穿刺进行腔内灌注化疗药液，治疗恶性肿瘤并浆膜腔转移４３例，取得良好效果．４３例８３次心包、胸、腹腔穿刺全部在超声引导和监视下完成，穿刺灌注成功率１００％．术后除有恶心、呕吐常规化疗的不良反应外，腹腔灌注患者７５．５％有不同程度腹胀，３．８％有腹痛。无一例发生出血、感染、化学药液外溢及损伤其它重要脏器等并发症．作者认为，本方法具有穿刺准确、安全简便、并发症少等诸多优点，可协助临床观察疗效或评价疗效提供依据，是腔内化疗的新途径，值得进一步推广应用．

Forty-three cases of malignant tumors with metastases to serous cavites were treated by interventional chemotherapy under ultrasound guidance and monitoring.43 cases(83 injections) were all successfully operated and followed up. After peritoneoclysis,besides the common side effects of chemotherapyie nausea and vomiting, 3.8% of the patients had abdominal pain and 75. 5% had abdominal distention. No complication of hemorrhage, infection, drug leakage or organ injury oceurred.It is suggested the method is safe easily to be used especially for the intracavitary chemotherapy of malignaant tumors and deserves to be widely employed.